Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisor
Sopharma has completed the initial stage of a strategic pharmaceutical portfolio acquisition
As part of Sopharma’s growth strategy to expand its regional market footprint, the company has recently completed the first stage of a transaction to acquire a large pharmaceutical product portfolio, including both consumer healthcare and prescription products.
Learn moreSopharma Group has acquired two pharmaceutical products in Poland
Sopharma Group has acquired Coffepirine and Kopiryna, two highly recognized medicines to treat headache. The acquisition will further expand the market presence of Sopharma Group in the Polish market and support the promising potential of the two pharmaceutical drugs.
Learn moreSopharma has agreed to acquire Pharmanova, a Serbian-based pharmaceutical company
Sopharma has signed a contract for the phased acquisition of the Serbian-based pharmaceutical manufacturer Pharmanova. The deal is structured in three steps, starting with the acquisition of 25% interest in December 2023, which is increased to 75% in 2024 and to 100% in 2025. With this transaction, Sopharma will further strengthen its market position in the Balkans and add to its family of businesses one of the biggest producers of branded herbal medicines and dietary products in Serbia.
Learn more
Jan-Frederik Kolthoff
Founder and CEO, move UP Gesellschaft für Gesundheitsmanagement mbH
Read more
Businesses are shaping the future through M&A
QUARTERLY M&A ACTIVITY: In 2024's Q4, Oaklins completed 90 M&A transactions, with TMT and Healthcare leading, reflecting innovation and strategic growth.
Learn more
Talk to our local advisors
Meet our global industry specialists
Michael S. Goldman
Oaklins TM Capital